This cost-effectiveness analysis of care options for group A streptococcus patients is the first to include community pharmacy as a possible point of care.
Donald G. Klepser, PhD, MBA
Advertisement
Articles by Donald G. Klepser, PhD, MBA
In this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by patients with cardiovascular disease.
In his Editorial, Dr. Klepser considers the effectiveness and the future of value-based insurance design.
Advertisement
Latest Updated Articles
- Are Patent Expirations the Answer to Improving Patient Adherence?
Published: December 1st 2008 | Updated:
- Adherence and Dosing Frequency of Common Medications for Cardiovascular Patients
Published: March 16th 2012 | Updated:
- Cost-Effectiveness of Pharmacist-Provided Treatment of Adult Pharyngitis
Published: April 13th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP
4
How Clinician-Led Partnerships Strengthen Post-Acute Care
5
